Merck is expected to announce a deal to buy a closely held biotechnology company in the early stages of developing a new diabetes treatment.
WSJ.com: What's News US, Wall Street Journal
Wed, 12/01/2010 - 6:16pm
Merck is expected to announce a deal to buy a closely held biotechnology company in the early stages of developing a new diabetes treatment.